Theriva Biologics, Inc. Preferred Stock, Convertible, Conversion Price, Decrease
Theriva Biologics, Inc. (TOVX) had Preferred Stock, Convertible, Conversion Price, Decrease of $1.22 per share as of 2022-08-03, per its 10-K filed 2024-03-25.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:PreferredStockConvertibleConversionPriceDecrease · last filed 2024-03-25
- 2021-01-27: Preferred Stock, Convertible, Conversion Price, Decrease $1.50.
USD
| Period end | Preferred Stock, Convertible, Conversion Price, Decrease |
|---|---|
| 2021-01-27 | $1.50 10-K · filed 2021-03-04 |
USD/shares
| Period end | Preferred Stock, Convertible, Conversion Price, Decrease | Preferred Stock, Convertible, Conversion Price, Decrease as first filed |
|---|---|---|
| 2022-08-03 | $1.22 10-K · filed 2024-03-25 | |
| 2021-01-27 | $15.00 10-K · filed 2023-03-30 | $1.50 10-K · filed 2021-03-04 |
| 2020-11-16 | $6.90 10-K · filed 2023-03-30 | $0.69 10-K · filed 2022-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |